Clinical Trials
- Asthma
PrecISE: Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network
- Ages18 years and older
- GenderBoth
- Tobacco Addiction
The interaction of flavor with nicotine form in adult smokers
- Ages21 years and older
- GenderBoth
- Children's Health, Diseases of the Respiratory Systems
Efficacy and Safety of OPN-375 186 ug Twice a Day (BID) in Adolescents with Bilateral Nasal Polyps
- Ages12 years - 17 years
- GenderBoth
- Orthopaedics, Muscle & Bone
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis (RAISE-XT)
- Ages40 years - 80 years
- GenderBoth
- Addictive Behavior, Mental Health & Behavioral Research, Tobacco Addiction
Switching to Potential Reduced Exposure Products in Adult Smokers (JUUL)
- Ages21 years - 77 years
- GenderBoth
- Addictive Behavior, Mental Health & Behavioral Research, Tobacco Addiction
Effect of Flavors and Nicotine on E-Cigarette Appeal and Use in Regular Tobacco-Product Users
- Ages18 years - 30 years
- GenderBoth
- Children's Health, Mental Health & Behavioral Research
Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension (D1AMOND)
- Ages6 years - 18 years
- GenderBoth
- Addictive Behavior, Mental Health & Behavioral Research, Tobacco Addiction
Effects of E-Cigarette Flavors on Adults TCORS 2.0
- Ages21 years - 50 years
- GenderBoth
- Addictive Behavior, Tobacco Addiction, COVID-19 Inpatient, COVID-19 Outpatient
Real-Time Surveillance of E-Cigarette, or Vaping, Product-Use Associated Lung Injury (EVALI)
- Ages18 years and older
- GenderBoth
- COVID-19 Inpatient, COVID-19 Outpatient
Long Covid: Understanding Immune, Symptom, and Treatment Experiences Nationwide (LISTEN Study)
- Ages18 years and older
- GenderBoth